A Multiple-Dose, Open-Label Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint / Musculoskeletal Pain or Soft Tissue Inflammation
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2009
At a glance
- Drugs Ketoprofen (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions; Registrational
- 24 Mar 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Actual patient number (491) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.